Giammanco G, Li Volti S, Salemi I, Giammanco Bilancia G, Mauro L
Institute of Hygiene and Preventive Medicine, University of Catania, Italy.
Eur J Epidemiol. 1993 Mar;9(2):199-202. doi: 10.1007/BF00158792.
A combined vaccine against measles (Edmonston-Zagreb 19 strain), mumps (Rubini strain) and rubella (Wistar RA 27/3 strain) was administered to a group of 46 children aged 10-12 months simultaneously with booster doses of compulsory diphtheria-tetanus toxoid and oral poliovirus vaccine. A second group of 53 children aged 15-24 months who had received booster doses of the compulsory vaccines 5 to 12 months before was also vaccinated. The same seroconversion rates (100%) and similar antibody titers for rubella were observed in both groups. The same seroconversion rates for mumps (93%) and similar rates for measles (98 and 94%) were observed in the two groups. Significantly lower antibody titers for measles and mumps were found in the first group, but they were compensated by an earlier protection, a reduction of number of visits for immunization, costs for the community, and improvement in parental compliance. These results confirm that Edmonston-Zagreb 19 and Rubini strains are still immunogenic even when they are combined with Wistar RA 27/3 strain. Moreover, a long term follow-up in order to verify the persistence of protective antibody levels in both groups of children, could suggest that combined measles, mumps and rubella vaccine could be given earlier (at 10-12 months of age), simultaneously with booster doses of diphtheria and tetanus toxoid and of trivalent oral poliovirus vaccine.
一种针对麻疹(埃德蒙斯顿-萨格勒布19株)、腮腺炎(鲁比尼株)和风疹(Wistar RA 27/3株)的联合疫苗被接种给了一组46名10至12个月大的儿童,同时还接种了白喉-破伤风类毒素加强剂和口服脊髓灰质炎疫苗。另一组53名15至24个月大的儿童,他们在5至12个月前已接种了强制疫苗的加强剂,也接种了该联合疫苗。两组中观察到风疹的血清转化率相同(100%)且抗体滴度相似。两组中腮腺炎的血清转化率相同(93%),麻疹的血清转化率相似(98%和94%)。第一组中麻疹和腮腺炎的抗体滴度明显较低,但它们通过更早的保护、减少免疫接种就诊次数、社区成本以及提高家长依从性得到了弥补。这些结果证实,即使埃德蒙斯顿-萨格勒布19株和鲁比尼株与Wistar RA 27/3株联合使用,它们仍然具有免疫原性。此外,为了验证两组儿童中保护性抗体水平的持久性而进行的长期随访可能表明,麻疹、腮腺炎和风疹联合疫苗可以更早(在10至12个月大时)接种,同时接种白喉和破伤风类毒素加强剂以及三价口服脊髓灰质炎疫苗。